Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FR-133605 effective in preclinical models of rheumatoid arthritis, septic shock

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

Searle and Yamanouchi to codevelop celecoxib

April 26, 1996

Hisamitsu discloses new cyclooxygenase inhibitor

April 26, 1996

Nihon Iyakuhin's NSAID research bears fruit

April 26, 1996

TNF-bp in clinical testing

April 19, 1996

Amiprilose advances to phase III in rheumatoid arthritis

April 12, 1996

COX-2 inhibitor research continues at Merck Frosst

April 12, 1996

PEG-rhSOD advancing in preclinical phase

April 5, 1996

Colloral dose refinement study underway

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...